Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vagus Nerve Stimulation in Fibromyalgia

NCT: NCT06237595 · COMPLETED

NCT IDNCT06237595
StatusCOMPLETED
Start Date2023-09-30
Completion2025-03-15
SponsorKasr El Aini Hospital (OTHER)
First posted
Last updated

Brief Summary

Vagus nerve stimulation is thought to reduce sympathetic nerve outflow and so can improve sympathetic hyperactivity in fibromyalgia patients. We aimed in the current study, to evaluate the effect of the cervical transcutaneous vagus nerve stimulation in comparison to conventional medical treatment in Egyptian fibromyalgia patients.

Frequently Asked Questions

What is Vagus Nerve Stimulation in Fibromyalgia?

Vagus Nerve Stimulation in Fibromyalgia is a clinical trial registered under NCT06237595. Current status: COMPLETED.

What is the status of NCT06237595?

The current status of NCT06237595 (Vagus Nerve Stimulation in Fibromyalgia) is: COMPLETED.

When did Vagus Nerve Stimulation in Fibromyalgia start?

Vagus Nerve Stimulation in Fibromyalgia started on 2023-09-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.